Green Planet Bioengineering Co Ltd

Green Planet Bioengineering Co Ltd

GPLB
Green Planet Bioengineering Co LtdUS flagOther OTC
0.01
USD
+0.00
- -
260,083.00Market Cap
Green Planet Bioengineering Co Ltd
GPLB
(Other OTC)

Recent

price

0.01

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
-0.57
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
0.05
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.03
-0.03
-0.03
-0.03
-0.04
-0.04
-0.04
-0.04
-0.04
-0.04
-0.05
-0.05
-0.05
-0.05
-0.05
- -
-0.06
Book Value per Share
-0.01
-0.01
- -
- -
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
-0.02
-0.02
-0.02
-0.02
-0.02
- -
-0.03
Tangible Book Value per Share
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
- -
20
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
20
20
20
Market Capitalization
1
- -
- -

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
1
1
Payables & Accruals
- -
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
13.1%
9.64%
7.71%
Free Cash Flow
- -
2.75%
4.28%
Net Income, GAAP
3.61%
3.75%
0.84%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Green Planet Bioengineering Co Ltd (GPLB) operates as a shell company with no significant ongoing business operations or revenues, primarily serving the purpose of acquiring or merging with an existing business; it previously engaged in the manufacture, marketing, and sale of extracts from tobacco leaf residues, including bio-ecological products such as CoQ10, solanesol, raw chemical materials, organic fertilizers, pesticides, and organic health nutrients and supplements derived from tobacco residues in the People's Republic of China. The company, founded in 2004 and formerly known as Mondo Acquisition II Inc until its name change on October 2, 2008, maintains headquarters at 20807 Biscayne Blvd, Suite 203, Aventura, Florida 33180, United States, with prior main operations in Sanming and Fuzhou, China; it functions as a subsidiary of Global Fund Holdings Corp (also referenced as ONE Bio Corp with approximately 92.51% ownership) and reports under the financials sector in shell companies industry with SIC code 6799. Recent developments include the resignation of its independent auditor Assurance Dimensions LLC in May 2025, coinciding with the firm's decision to cease auditing publicly traded companies; a quarterly 10-Q filing on November 14, 2024, for the period ended September 30, 2024, disclosing a net loss of $22,753, working capital deficit of $452,343, accumulated deficit of $1,081,963, and reliance on related-party advances amid substantial going-concern doubts without such support; no new product launches, funding rounds, acquisitions, partnerships, or operational restarts noted in the last 1-2 years, with 176 employees listed and Jordan Weingarten serving as CEO, President, CFO, and Director.